Narek Shaverdian, MD

Memorial Sloan Kettering Cancer Center
New York, NY, United States

Disclosures:

• Employment: Memorial Sloan Kettering:Radiation Oncologist:Employee
• Compensation: Amgen: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 2028 ;Novartis: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 2026
• Ownership: none
• Leadership: none

Presentation(s):

• 246 - Exploratory Analysis of ctDNA and Imaging Response in the Phase I/II CHORUS Study of Canakinumab with Chemoradiation and Durvalumab Consolidation for Stage III NSCLC

  Monday, September 30, 2024
  5:40 PM – 5:50 PM ET